ASGCT News: Kelonia Lentiviral Particles May Solve In Vivo Delivery Hurdles for CAR T Cells by rob@robmaguiredesigns.com | May 17, 2023 | News
Med City News: As Cell Therapy Gains Ground, Efforts Emerge to Improve CAR T-Manufacturing by rob@robmaguiredesigns.com | Jan 26, 2023 | News
BioWorld: Keeping it simple: Kelonia raises a $50M series A by brian@orrbitt.com | May 2, 2022 | News
Kelonia Scores $50M to Propel In Vivo Gene Delivery Platform by brian@orrbitt.com | Apr 28, 2022 | News